12
Participants
Start Date
February 28, 2012
Primary Completion Date
June 1, 2012
Study Completion Date
GSK2585823
CLDM1%/BPO3%
GSK Investigational Site, Tokyo
Lead Sponsor
GlaxoSmithKline
INDUSTRY